<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="http://www.loc.gov/MARC21/slim">

  <leader>01786nam a22001817a 4500</leader>
  <controlfield tag="003">OSt</controlfield>
  <controlfield tag="005">20250328140349.0</controlfield>
  <controlfield tag="008">250328b        |||||||| |||| 00| 0 eng d</controlfield>
  <datafield tag="040" ind1=" " ind2=" ">
    <subfield code="c">NVSU</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Duyugen, Noviglyn C.</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">In vitro antibacterial effect of tasmannia piperita (hopar or sapal) extract against Escherichia coli and staphylococcus aureus/</subfield>
    <subfield code="c">Noviglyn C. Duyugen</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="a">Bayombong:</subfield>
    <subfield code="b">Nueva Vizcaya State University,</subfield>
    <subfield code="c">2018</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a">xv, 43 leaves :</subfield>
    <subfield code="b">illustration, photos ;</subfield>
    <subfield code="c">28 cm.</subfield>
  </datafield>
  <datafield tag="500" ind1=" " ind2=" ">
    <subfield code="a">The study determines the zone of inhibition of Tasmannia piperita, compared the in-vitro antibacterial efficacy with the commercially available antibiotics (penicillin G and gentamicin) and identify the most effective concentration capable of inhibiting the growth of Staphylococcus aureus and Escherichia coli. The study experimented was laid out in a Randomized Complete Block Design (RCBD) with the following treatments Treatment 1-penicillin G and gentamicin (antibiotic disc), Treatment 2-25% Tasmannia piperita crude extract, Treatment 3-50% Tasmannia piperita crude extract, Treatment 4-75% Tasmannia piperita crude etract, Treatment 5-100% Tasmannia piperita crude extract, Treatment 6-negative control 95% ethanol. Each treatment was replicated three times. 
Based on the result of the study, Tasmanni piperita crude extract inhibited zones of inhibition but not significant because it indicated no antibacterial efficacy both against Escherichia coli and Staphylococcus aureus, compared to penicillin that exhibited moderate antibacterial efficacy and gentamicin that possess high antibacterial efficacy.
</subfield>
  </datafield>
  <datafield tag="500" ind1=" " ind2=" ">
    <subfield code="a">Thesis (Doctor of Veterinary Medicine)</subfield>
  </datafield>
  <datafield tag="504" ind1=" " ind2=" ">
    <subfield code="a">includes appendices and bibliographical references.</subfield>
  </datafield>
  <datafield tag="942" ind1=" " ind2=" ">
    <subfield code="2">ddc</subfield>
    <subfield code="c">U</subfield>
    <subfield code="n">0</subfield>
  </datafield>
  <datafield tag="999" ind1=" " ind2=" ">
    <subfield code="c">456</subfield>
    <subfield code="d">456</subfield>
  </datafield>
  <datafield tag="952" ind1=" " ind2=" ">
    <subfield code="0">0</subfield>
    <subfield code="1">0</subfield>
    <subfield code="2">ddc</subfield>
    <subfield code="4">0</subfield>
    <subfield code="7">0</subfield>
    <subfield code="a">NVSUBAY</subfield>
    <subfield code="b">NVSUBAY</subfield>
    <subfield code="c">GR</subfield>
    <subfield code="d">2025-03-21</subfield>
    <subfield code="e">Donation</subfield>
    <subfield code="l">0</subfield>
    <subfield code="o">U (DVM) 	D988i 2018</subfield>
    <subfield code="p">U1241</subfield>
    <subfield code="r">2025-03-28 14:04:21</subfield>
    <subfield code="w">2025-03-28</subfield>
    <subfield code="y">U</subfield>
  </datafield>
</record>
